Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003878348 | SCV004676992 | benign | Gorlin syndrome | 2023-02-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004369595 | SCV005034211 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-12-20 | criteria provided, single submitter | clinical testing | The p.E992G variant (also known as c.2975A>G), located in coding exon 18 of the PTCH1 gene, results from an A to G substitution at nucleotide position 2975. The glutamic acid at codon 992 is replaced by glycine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |